UPC Analytics
ENDE
Overview · Filed: Jul 17, 2025

UPC_CFI_657/2025

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

Procedural & sub-applicationsCosts AssessmentsDusseldorf LDGenericWritten Phase
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Curio Bioscience Inc.
Reps: Tilman Müller-Stoy (Bardehle Pagenberg); Martin Drews (Bardehle Pagenberg); Axel Berger (Bardehle Pagenberg)

Respondents

  • 10x Genomics, Inc.
Reps: Agathe Michel-De Cazotte (Carpmaels & Ransford LLP); Cameron Marschall (Carpmaels & Ransford LLP)
Judges
  • Ronny Thomas
  • Berenice Thom
  • Andras Kupecz
  • Martin Schmidt
Patents
  • EP2697391
CPC codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Sector: Biotechnology

Outcome
Costs only
Filed: Jul 17, 2025
First decided: Feb 2, 2026
Language: English

The Düsseldorf Local Division issued a cost decision following the merits judgment of 16 June 2025 (10x Genomics v. Curio Bioscience), apportioning costs of PI proceedings and main action proceedings at a 30%/70% ratio (claimant/defendant) based on the parties' respective success.

Open on UPC Registry